Anderson et al., 2018 - Google Patents
Avoidance of Overt Precipitation and Patient Harm Following Errant Y‐Site Administration of Calcium Chloride and Parenteral Nutrition Compounded With Sodium …Anderson et al., 2018
- Document ID
- 10965261199151187222
- Author
- Anderson C
- Stidham C
- Boehme S
- Cash J
- Publication year
- Publication venue
- Nutrition in Clinical Practice
External Links
Snippet
Calcium phosphate precipitates present 1 of many challenges associated with parenteral nutrition (PN) compounding. Extensive research has led to the establishment of solubility curves to guide practitioners in the prescription and preparation of stable PN. Concurrent …
- 235000016236 parenteral nutrition 0 title abstract description 75
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vallerand et al. | Davis's Canadian Drug Guide for Nurses | |
Boullata et al. | ASPEN clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing | |
Mirtallo et al. | Safe practices for parenteral nutrition | |
Newton et al. | Calcium and phosphate compatibility: revisited again | |
Reber et al. | Pharmaceutical aspects of artificial nutrition | |
Hermanspann et al. | Incidence and severity of prescribing errors in parenteral nutrition for pediatric inpatients at a neonatal and pediatric intensive care unit | |
Thibault | Possible incompatibility between amino acids and copper in solutions for pediatric parenteral nutrition | |
Stern et al. | Alkalinizing agents: a review of prescription, over-the-counter, and medical food supplements | |
Maisonneuve et al. | Parenteral nutrition practices in hospital pharmacies in Switzerland, France, and Belgium | |
Mühlebach et al. | Practical handling of AIO admixtures–guidelines on parenteral nutrition, chapter 10 | |
Miller | Commercial premixed parenteral nutrition: is it right for your institution? | |
Sacks | Safety surrounding parenteral nutrition systems | |
Bouchoud et al. | Maximizing calcium and phosphate content in neonatal parenteral nutrition solutions using organic calcium and phosphate salts | |
Beattie et al. | Comparison between premixed and compounded parenteral nutrition solutions in hospitalized patients requiring parenteral nutrition | |
Palm et al. | Copper and zinc deficiency in a patient receiving long‐term parenteral nutrition during a shortage of parenteral trace element products | |
Farhan et al. | Stability and compatibility of parenteral nutrition solutions; a review of influencing factors | |
Mays et al. | Safety in parenteral nutrition compounding | |
de Oliveira et al. | Aluminum content in intravenous solutions for administration to neonates: role of product preparation and administration methods | |
Busch et al. | Use of piggyback electrolytes for patients receiving individually prescribed vs premixed parenteral nutrition | |
Hardy et al. | Basic principles for compounding all-in-one parenteral nutrition admixtures | |
Anderson et al. | Avoidance of Overt Precipitation and Patient Harm Following Errant Y‐Site Administration of Calcium Chloride and Parenteral Nutrition Compounded With Sodium Glycerophosphate | |
Murphy et al. | Home parenteral nutrition and intravenous fluid errors discovered through novel clinical practice of reconciling compounding records: a case series | |
Mirtallo | Parenteral nutrition ordering processes | |
Abrams et al. | Micronutrient requirements of high-risk infants | |
Keady et al. | National Patient Safety Agency: improving patient safety across all critical care areas |